BioLife Solutions, Inc. (NASDAQ:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"), announced that the Company is scheduled to present at the 2015 Marcum MicroCap Conference.
The Company is scheduled to present at the Conference at 1:30 p.m. EDT on Wednesday, May 27, 2015 at the Grand Hyatt Hotel in New York City and will be available to participate in one-on-one meetings with investors and analysts who are registered to attend the conference. The Company's presentation can be found at the following link: Investor Presentation May 2015.
BioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions and precision thermal shipping products for cells, tissues, and organs. BioLife also performs contract aseptic media formulation, fill, and finish services. The Company's proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife's enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs. For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.
Media & Investor Relations
Senior Vice President, Chief Financial Officer